SKI Market

Indian Indices

Nifty

25,405.30 -48.10
(-0.19%)

Sensex

83,239.47 -170.22
( -0.20%)

Bank Nifty

56,791.95 -207.25
( -0.36%)

Nifty IT

38,854.30 -24.80
( -0.06%)

Global Indices

Nasdaq

44,498.76 -17.19
(-0.04%)

Dow Jones

6,247.07 28.06
(0.45%)

Hang Seng

39,705.85 -56.63
(-0.14%)

Nikkei 225

8,823.20 48.51
(0.55%)

Forex

USD-INR

85.59 -0.04
(-0.04%)

EUR-INR

100.92 0.38
(0.38%)

GBP-INR

117.62 0.20
(0.17%)

JPY-INR

0.60 0.00
(0.46%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Novartis India Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500672

INE234A01025

317.91821

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NOVARTIND

25.74

2597.72

EPS(TTM)

Face Value()

Div & Yield %

40.87

2.38

Back

dr reddys laboratories ltd

Aerpace Industries reports standalone net loss of Rs 2.08 crore in the December 2024 quarter

Feb 07,2025

Net Loss of Aerpace Industries reported to Rs 2.08 crore in the quarter ended December 2024 as against net loss of Rs 0.24 crore during the previous quarter ended December 2023. Sales rose 30.00% to Rs 0.39 crore in the quarter ended December 2024 as against Rs 0.30 crore during the previous quarter ended December 2023.

Particulars	Quarter Ended
	Dec. 2024	Dec. 2023	% Var.
Sales	0.39	0.30	30
OPM %	-348.72	-76.67	-
PBDT	-1.27	-0.18	-606
PBT	-2.14	-0.26	-723
NP	-2.08	-0.24	-767

25,405.30 -48.10 (-0.19%)

83,239.47 -170.22 ( -0.20%)

56,791.95 -207.25 ( -0.36%)

38,854.30 -24.80 ( -0.06%)

44,498.76 -17.19 (-0.04%)

6,247.07 28.06 (0.45%)

39,705.85 -56.63 (-0.14%)

8,823.20 48.51 (0.55%)

85.59 -0.04 (-0.04%)

100.92 0.38 (0.38%)

117.62 0.20 (0.17%)

0.60 0.00 (0.46%)